Novartis AG News Headlines

NVS 
$94.13
*  
0.57
0.61%
Get NVS Alerts
*Delayed - data as of Sep. 30, 2014  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Acadia And Parkinson's Treatment Hopes
10/13/2013 5:54:00 PM - Seeking Alpha

My K.I.S.S. Dividend Portfolio 3rd Quarter Update
10/12/2013 7:00:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Flat to Higher; Immunogen up 6% on Licensing to Novartis
10/11/2013 8:07:36 AM - MT Newswires

Sector Update: Healthcare
10/11/2013 8:05:20 AM - MT Newswires

Ariad Shares Slip on Clinical Hold - Analyst Blog
10/10/2013 3:10:01 PM - Zacks.com

XOMA: A Hidden Gem In The Crowded Biotech Sector
10/10/2013 2:07:00 PM - Seeking Alpha

Tecfidera And The Revolution In Multiple Sclerosis Treatment
10/10/2013 8:48:00 AM - Seeking Alpha

Update on Sanofi's Aubagio - Analyst Blog
10/9/2013 4:27:56 PM - Zacks.com

8 Drug And Device 9% To 21% September Upsides Paced Healthcare Dogs
10/9/2013 3:00:00 PM - Seeking Alpha

Pipeline Progress at Novartis - Analyst Blog
10/9/2013 2:28:28 PM - Zacks.com

European Shares Fall As U.S. Government Shutdown Continues, Debt Ceiling Eyed
10/8/2013 12:25:19 PM - MT Newswires

PDL BioPharma in Financing Deals - Analyst Blog
10/7/2013 6:44:45 PM - Zacks.com

Encouraging Data on Novartis' Secukinumab - Analyst Blog
10/7/2013 2:31:58 PM - Zacks.com

Novartis - Make Money From COPD Opportunity
10/7/2013 1:59:00 PM - Seeking Alpha

Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
10/6/2013 8:57:00 PM - Seeking Alpha

My Dividend Portfolio: Q3 2013 Update
10/4/2013 6:51:00 PM - Seeking Alpha

Affordable Care Act: Eye Care Shopping List
10/4/2013 3:55:00 PM - Seeking Alpha

Investing Smart: Biotechs, Effective Therapies And Shareholder-Friendly CEOs
10/2/2013 8:19:00 AM - Seeking Alpha

10 Carnevale Solid 40 DiviDogs Quest 6% To 26% Sept. Upsides
10/1/2013 7:22:00 AM - Seeking Alpha

3 Companies Developing The Future Of Cancer Therapy
9/27/2013 3:26:00 PM - Seeking Alpha

Amgen: US Filgrastim Patent Challenge
9/23/2013 11:18:00 AM - Seeking Alpha

Questcor Pharmaceuticals: Undervalued Next To Peers Even After A 2013 Run
9/23/2013 9:18:00 AM - Seeking Alpha

China Biotech In Review: Novartis Has A Novel Scandal Potentially Brewing
9/22/2013 5:19:00 AM - Seeking Alpha

Is Biodel A Buy Or Sell?
9/19/2013 4:40:00 PM - Seeking Alpha

Biogen: All Reasons For Bulls To Be Happy
9/16/2013 11:38:00 AM - Seeking Alpha